Brind.

Stock trading activity for multiple companies, including Royalty Pharma, TTM Technologies, Trane Technologies, and others, was reported on the Nasdaq exchange on August 30, 2026.

1 report, 1 independent Updated Aug 30

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Royalty Pharma TTM Technologies Trane Technologies

Keep exploring

The entities involved

Royalty Pharma
biopharmaceutical company based in New York City
- Visteon filed transaction details with the SEC and traded on the Nasdaq stock exchange on June 6, 2026.Sun 17:49
- Royalty Pharma acquired a royalty interest in Amgen's drug Imdelltra.Sun 02:34
TTM Technologies
American PCB manufacturer

Nothing else this week.
Trane Technologies
irish-domiciled holding company
- Trane Technologies filed required quarterly reports with the Securities and Exchange Commission on June 15, 2026.Mon 02:05
- Analyst coverage was initiated for Almonty Industries, Trane Technologies, and Honeywell International, Inc. on September 25, 2026.Fri 19:27

Coverage

Newest first; wire copies grouped

Aug 30dailypolitical.com